RELMADA THERAPEUTICS INC's ticker is RLMD and the CUSIP is 75955J402. A total of 84 filers reported holding RELMADA THERAPEUTICS INC in Q4 2023. The put-call ratio across all filers is 2.38 and the average weighting 0.0%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q2 2024 | $8,262 | -81.8% | 2,754 | -71.8% | 0.00% | -100.0% |
Q1 2024 | $45,365 | +347.4% | 9,756 | +298.4% | 0.00% | – |
Q4 2023 | $10,139 | +97.6% | 2,449 | +43.2% | 0.00% | – |
Q3 2023 | $5,130 | -56.7% | 1,710 | -64.5% | 0.00% | – |
Q2 2023 | $11,850 | +118400.0% | 4,817 | +4.3% | 0.00% | – |
Q1 2023 | $10 | -88.1% | 4,619 | -80.8% | 0.00% | -100.0% |
Q4 2022 | $84 | -99.7% | 24,041 | +2721.7% | 0.00% | +200.0% |
Q3 2022 | $32,000 | +14.3% | 852 | -42.0% | 0.00% | 0.0% |
Q2 2022 | $28,000 | +366.7% | 1,469 | +606.2% | 0.00% | – |
Q1 2022 | $6,000 | -78.6% | 208 | -83.0% | 0.00% | – |
Q4 2021 | $28,000 | +55.6% | 1,227 | +80.2% | 0.00% | – |
Q3 2021 | $18,000 | -45.5% | 681 | -34.6% | 0.00% | -100.0% |
Q2 2021 | $33,000 | -47.6% | 1,041 | -42.1% | 0.00% | 0.0% |
Q1 2021 | $63,000 | +70.3% | 1,798 | +52.6% | 0.00% | 0.0% |
Q4 2020 | $37,000 | -92.0% | 1,178 | -90.4% | 0.00% | -80.0% |
Q3 2020 | $462,000 | +1055.0% | 12,282 | +1263.2% | 0.01% | +150.0% |
Q2 2020 | $40,000 | -52.4% | 901 | -58.0% | 0.00% | -71.4% |
Q4 2019 | $84,000 | – | 2,143 | – | 0.01% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Deep Track Capital, LP | 2,837,818 | $9,903,985 | 0.42% |
Sio Capital Management, LLC | 235,500 | $821,895 | 0.30% |
Sio Capital Management, LLC | 235,600 | $822,244 | 0.30% |
apricus wealth, LLC | 77,329 | $269,878 | 0.25% |
RTW INVESTMENTS, LP | 2,067,824 | $7,216,706 | 0.15% |
PARSONS CAPITAL MANAGEMENT INC/RI | 496,254 | $1,731,926 | 0.14% |
Aristides Capital LLC | 69,322 | $241,934 | 0.12% |
XTX Topco Ltd | 129,387 | $451,561 | 0.10% |
AdvisorShares Investments LLC | 81,362 | $283,953 | 0.08% |
Ikarian Capital, LLC | 65,491 | $228,563 | 0.06% |